The causative agents of leprosy are the well-known Mycobacterium leprae and the newly discovered Mycobacterium lepromatosis. This agent was found in 2008, and it was found to be the cause of diffuse lepromatous leprosy in two Mexican patients. Objective: The objective of this work was to determine if M. leprae and M. lepromatosis were present in formalin-fixed and paraffin-embedded skin samples from cases from different regions in Mexico. Methods: A total of 41 skin samples were obtained from 11 states of Mexico. All patients' samples were diagnosed by clinical and histopathological analyses. Total DNA was isolated using a Qiagen-DNeasy blood and tissue kit and molecular identification was achieved by two semi-nested polymerase chain reactions. Results: The 41 patient included 33 samples from men and 8 samples from women; 29 samples were polymerase chain reaction 
INTRODUCTION
Leprosy is a mycobacterial infection, which affects primarily the skin, peripheral nerves, eyes, and mucous membranes of the upper respiratory tract 1 . This disease has plagued humans for millennia and remains a significant public health problem 2 . Worldwide, it is an outstanding cause of morbidity due to physical handicaps and social stigma. Until 2013, the World Health Organization reported a cases-rate of ＞10 per 100,000 population in India and Brazil; 1∼10 per 100,000 in Africa and Far East; ＜1 per 100,000 in Latin America, United States, 
MATERIALS AND METHODS

Samples
DNA extraction and polimerase chain reaction (PCR)
The formalin-fixed and paraffin-embedded tissue samples were process to remove paraffin using xylene protocol. Total DNA was isolated using a DNeasy blood and tissue kit (Qiagen, Ventura, CA, USA) according to the manufacturer's instructions. DNA concentration was determined by spectrophotometry at 260 nm. Molecular identification was achieved by two semi-nested PCR, the first PCR used primers AFBFO (5-gcgtgcttaacacatgcaagtc-3) and MLER4 (5-ccacaagacatgcgccttgaag-3 
RESULTS
Forty-one patients were diagnosed with leprosy by clinical and histopathological analysis; twenty-nine samples were PCR-positive to Mycobacterium (70.73%) and twelve samples were PCR-negative (29.27%). From those twenty-nine samples, thirteen were PCR-positive to M. leprae (44.83), eight to M. lepromatosis (27.58%) and eight were positive to both species (27.58%). The forty-one patients included thirty-three samples from men and eight samples from women. The average age was 52 years, range from 23 to 78 years-old. The 29 PCR-positive samples to Mycobacterium; included 13 M. leprae positive (11 men and 2 women), and 8 M. lepromatosis positive (7 men and a woman). The eight patients positive for both species, six were men and two women. From the twelve negative samples, nine were men and three women. Regarding the geographic region; M. leprae was found in six samples from Yucatan, 3 from Michoacán, and one from Mexico City, Mexico state, Guerrero and Puebla (13 samples). M. lepromatosis was found in two samples from Guerrero, 2 from Michoacán, 2 from Yucatan, 1 from Guanajuato, and 1 from Quintana Roo (8 samples). The dual infection was present in six samples from Yucatan, one from Campeche and one from Oaxaca. The twelve negative samples were; five from Guerrero, two from Morelos, two from Guanajuato, two from Yucatan, and one from Michoacan. The histopathological diagnosis observed included; Nodular lepromatous leprosy (NLL) (twenty-one samples); DLL (six samples); and Borderline leprosy (BL) (fourteen samples).
In the twenty nine PCR-positive samples, fourteen showed the NLL form, four showed the DLL form, and eleven the BL form. In the twelve samples negative to Mycobacterium, seven showed the NLL form, two showed the DLL form and three the BL form. In sum, the twenty-nine positive samples to Mycobacterium showed a distribution profile of eight samples with the NLL form positive to M. leprae, five to M. lepromatosis and one positive to both. The DLL form was present in two positive samples to M. lepromatosis, and two samples positive to both. The BL form was shown in five positive samples to M. leprae, one to M. lepromatosis, and five positive to both ( In our study, it was greater, up to 19% (8/41) ( Table 1) . Interestingly, the origin of most of the dual infections was the Yucatan peninsula, an area known to have frequent leprosy cases 11 , except for a case from Oaxaca 6-8 .
M. lepromatosis has been related as the specific cause of the severe DLL form 13, 14 . Since its discovery, its prevalence and significance has raised the scientific interest. According to our findings, M. lepromatosis may cause the NLL and BL ( Table 1 ). Given that M. lepromatosis is not geographically restricted to Mexico as it has been identified in America and Asia; Brazil, Myanmar, Canada, and Singapore 12, [15] [16] [17] [18] [19] , and that it can participates in dual infections in Leprosy endemic areas, M. lepromatosis should be taken on account for diagnosis worldwide. However as it has been observed in another papers DLL is related only with M. lepromtosis alone or with dual infection, but not only with M. leprae, it could explain the severity of these cases 13 .
Finally, these findings add evidence to the M. leprae and M. lepromatous distribution and clinical forms in the Mexican territory, and may aid to clarify the Lucio's phenomenon etiological agent 20, 21 .
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